Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment

NCT02471222 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Walking Impairment
Multiple Sclerosis

Interventions

DRUG: ADS-5102
OTHER: Placebo

Sponsor

Adamas Pharmaceuticals, Inc.